14 results
425
EX-99.2
INFIQ
Infinity Pharmaceuticals, Inc.
20 Jun 23
Business combination disclosure
8:02am
use, as well as HPV infection Incidence of HPV-caused SCCHN is increasing over time Men are over twice as likely to be diagnosed with SCCHN as women
8-K
EX-99.2
INFIQ
Infinity Pharmaceuticals, Inc.
20 Jun 23
Overview and Update on Pending Merger to Advance Three Promising Clinical
8:00am
use, as well as HPV infection Incidence of HPV-caused SCCHN is increasing over time Men are over twice as likely to be diagnosed with SCCHN as women
8-K
EX-99.2
INFIQ
Infinity Pharmaceuticals, Inc.
5 Nov 18
Infinity Pharmaceuticals Provides Company Update and Third Quarter 2018 Financial Results
4:10pm
Toxicity
Based on its mechanism of action, OPDIVO can cause fetal harm when administered to a pregnant woman. Advise pregnant women of the potential … , advise women to discontinue breastfeeding during treatment.
Serious Adverse Reactions
In Checkmate 037, serious adverse reactions occurred in 41
8-K
EX-99.1
o28ysgdz4xmsv6
4 Feb 14
Infinity Announces Promotion of David A. Roth to Chief Medical Officer
12:00am
8-K
EX-99.2
dgdw 7oiztmp0
30 Oct 07
Infinity Announces Advancement of Lead Development Program
12:00am
8-K
EX-99.1
t8tudmsdo b5t31zci
5 Jun 07
This presentation contains forward-looking statements within the meaning of The Private Securities Litigation
12:00am
- Prev
- 1
- Next